Quick Answer
MEDICINOVA INC reported Research And Development Expense of $5.01 million for the year ending 2012.
- MEDICINOVA INC showed a decrease of -35.6% in Research And Development Expense from 2011 to 2012.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 28, 2013.
- XBRL data for this metric is available from 2009 to 2012 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2009 to 2012), MEDICINOVA INC's Research And Development Expense has declined by 53.9%.
- Historical annual values: Fiscal year 2012: $5.01 million | Fiscal year 2011: $7.78 million | Fiscal year 2010: $9.71 million | Fiscal year 2009: $10.87 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: